Stock Quote

Merck ready to quickly deploy Covid antiviral pill if it gets regulatory approval, CEO says

"We're on pace to have 10 million courses ready before the end of this year, and more than double that next year," Merck CEO Robert Davis told CNBC on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.